NRC Health
NRC
Positions held
Your positionsNRC isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $451.68M | Enterprise value | $538.80M | Trailing P/E | 85.08 | Forward P/E | 19.45 |
| PEG | 1.32 | Price / book | 68.99 | Beta | 0.28 | Dividend yield | 3.14% |
| Revenue growth | 4.0% | Earnings growth | — | Gross margin | 61.7% | Operating margin | -0.2% |
| Profit margin | 4.2% | ROE | 42.0% | ROA | 8.1% | Debt / equity | 13.81 |
| Current ratio | 0.65 | Free cash flow | $20.28M | Analyst recommendation | none | Mean target | $26.00 |
| 52w high | $23.68 | 52w low | $11.01 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $35.4M | $34.8M | $35.2M | $34.6M | $34.0M |
| Op margin | -9.1% | 16.0% | 13.3% | 22.4% | 4.7% |
| Net income | -$3.3M | $3.2M | $1.8M | $4.1M | -$0.1M |
| Gross margin | 61.7% | 60.8% | 60.4% | 64.2% | 61.9% |
| Gross profit | $21.8M | $21.2M | $21.3M | $22.2M | $21.1M |
| Operating income | -$3.2M | $5.6M | $4.7M | $7.7M | $1.6M |
- Revenue +2% vs prior quarter ($35M vs $35M).
- Gross margin 61.7% (was 60.8% prior quarter).
- Operating margin compressed to -9.1%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | — |
| Op margin | 16.4% | 24.6% | 27.0% | 30.7% | — |
| Net income | $11.6M | $24.8M | $31.0M | $31.8M | — |
| Gross margin | 61.9% | 60.2% | 62.3% | 62.4% | — |
| Gross profit | $85.0M | $86.1M | $92.6M | $94.5M | — |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-28 · NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
2026-09-25 · NRC Health's Dividend Analysis
2026-09-02 · KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
2026-09-01 · NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
2026-08-12 · Resideo Technologies Names New CFO
2026-08-12 · Resideo Appoints Shane Harrison as Chief Financial Officer
2026-08-10 · Record Backlog Powers NRC Health’s (NRC) Upward Potential
2026-08-07 · Top Stock Reports for SpaceX, Arista Networks & Boeing
2026-08-03 · NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
2026-07-30 · New NRC Health Research Reveals What Drives Patient Loyalty Beyond Access
2026-07-29 · NRC Health (NRC) Q2 2026 Earnings Call Highlights: Strong TRCV Growth Amid Market Uncertainty
Price (daily)
Full chart · RSI · MACD · patterns